- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about FLGT
Recent news which mentions FLGT
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
Fulgent Genetics, Inc. (FLGT) Q4 2021 Earnings Call Transcript
February 23, 2022
Tickers
FLGT
From Motley Fool
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
Big Tech's Big Returns and Sports Business in the Spotlight
February 14, 2022
From Motley Fool
This Sector is 13% of the Stock Market and Has Lifelong Potential
February 10, 2022
From Motley Fool
The Most Important Chart for Fulgent Genetics Shareholders
February 10, 2022
Tickers
FLGT
From Motley Fool
Why Fulgent Genetics Stock Plummeted 36.5% Last Month
February 07, 2022
Tickers
FLGT
From Motley Fool
6 Stocks That Could Soar If New Coronavirus Variants Emerge
February 04, 2022
From Motley Fool
This Breakout Healthcare Growth Stock Is Too Cheap to Miss
January 26, 2022
Tickers
FLGT
From Motley Fool
Why Shares of Fulgent Genetics Nearly Doubled in 2021
January 09, 2022
Tickers
FLGT
From Motley Fool
3 COVID Stocks That Could Double in 2022
January 03, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
January 03, 2022
From Benzinga
2 Cheap Growth Stocks to Buy for 2022
January 01, 2022
From Motley Fool
My 2 Favorite Healthcare Stocks for 2022
December 29, 2021
From Motley Fool
Corona Doom 3.0: Omicron Surge. Profiting From The Boom In COVID-19 Testing Due To The Omicron Wave
December 22, 2021
From Benzinga
5 Value Stocks In The Healthcare Sector
December 20, 2021
From Benzinga
Is Fulgent Genetics a Good Healthcare Stock to Buy?
December 08, 2021
From Motley Fool
How Wide Is Fulgent Genetics' Moat?
December 03, 2021
From Motley Fool
3 Stocks That Could Make You Richer in December (and Beyond)
December 02, 2021
From Motley Fool
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
December 02, 2021
From Benzinga
Jim Cramer Weighs In On Carnival, Canadian Pacific Railway And More
December 02, 2021
From Benzinga
56 Biggest Movers From Friday
November 29, 2021
From Benzinga
48 Stocks Moving In Friday's Mid-Day Session
November 26, 2021
From Benzinga
3 Small-Cap COVID Stocks With Huge Upside
November 25, 2021
From Motley Fool
The Monster Business Lurking Behind Fulgent's COVID Results
November 24, 2021
From Motley Fool
A Look Into Healthcare Sector Value Stocks
November 22, 2021
From Benzinga
3 Healthcare Stocks That Are Too Cheap to Ignore
November 22, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.